It has been quite an unusual couple of months during the first part of 2020 due to global pandemic, COVID-19, but Devana Solutions, LLC has proven to be more essential than ever, keeping sites and their employees connected throughout the study startup process. We are honored to be such a valuable asset to our client-partners in the clinical research industry, as they continue working hard to bring much needed therapies and vaccines to those who need them most.
One of our outstanding client-partners, working hard to make a difference in the clinical research industry, is Del Sol Research Management in Tucson, Arizona. Del Sol focuses primarily on Gastrointestinal Disease, Hepatology, Internal Medicine, Women’s Health and Medical Device studies. With two convenient locations and fifteen full-time employees, including a Recruitment Manager, it is Del Sol’s mission to increase clinical research awareness within their community. In addition to the usual advertising and outreach that most sites do to increase their participant-base, Del Sol takes their efforts a step further by engaging with local advocacy groups and physicians to bring free health screens to impoverished populations, while educating them on clinical research. “All of these collaborations with our medical peers in the community not only increase study awareness, but also allow Del Sol and our employees to give back to our local community, especially in the poorer areas of our metropolitan area. We, as a company, are very passionate about improving the health and providing health care access to the Tucson community,” said Wendy Hotz, President, Del Sol Research Management.
Del Sol’s Senior VP of Clinical Operations was interviewed recently on a local Spanish television station, addressing the growing interest in clinical research within the Tucson Hispanic community and providing answers to questions that research-naïve individuals may have. It is becoming increasingly known that the Hispanic population has a higher rate of Nonalcoholic Fatty Liver Disease than other ethnicities. Since this disease can be silent for years before symptoms arise, the need for faster diagnosis is more important than ever, so patients can make the necessary lifestyle changes earlier to combat this deadly disease. Thanks to their in-house Fibroscan®, Del Sol is able to quickly measure liver fibrosis and steatosis of their study participants, making Del Sol an asset to Sponsors and CROs on GI and Hepatic indication-related clinical trials. In addition to the application of their Fibroscan®, Del Sol has developed expertise in a number of advanced procedures, including serial PK studies, complex infusions, endoscopy, colonoscopy, bile duct stent placement, flexible sigmoidoscopy, biopsy collection from various tissues, sample processing and specimen management, pulmonary function testing and intrauterine procedures.
With their vast experience and dedication to their patients, staff and CRO/Sponsor relationships, it is no surprise that Del Sol’s excellent reputation precedes them. We are humbled that they have chosen to partner with Devana Solutions, LLC to continue to revolutionize their clinical trial processes by leveraging our innovative technology platform. We can’t wait to see what the rest of this year brings for Del Sol!
About Devana Solutions, LLC
Devana Solutions, LLC is developer and provider of cloud-based SaaS technology driven by a core belief that data transparency through technology is critical to aligning the top performing research organizations at the investigative site level with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease. Devana offers technology to standardize operational workflows, particularly in study startup, across site functions while allowing for the automated capture, analysis and display of real time performance data across clinical trial industry stakeholders. For more information about Devana Solutions, LLC visit: www.DevanaSolutions.com.